These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 30119241)

  • 61. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y; Ren J; Liu K; Tang LM
    World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
    Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
    Mao Y; Liu J; Zhang D; Li B
    Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
    Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
    Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis.
    Wang W; Wu D; He X; Hu X; Hu C; Shen Z; Lin J; Pan Z; He Z; Lin H; Wang M
    Cancer Lett; 2019 Sep; 460():18-28. PubMed ID: 31207321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-181d is a tumor suppressor in human esophageal squamous cell carcinoma inversely regulating Derlin-1.
    Li D; Shi M; Ji H; Chen G; Jiang H; Wang Z
    Oncol Rep; 2016 Oct; 36(4):2041-8. PubMed ID: 27572270
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma.
    Yi J; Jin L; Chen J; Feng B; He Z; Chen L; Song H
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):159-169. PubMed ID: 28069583
    [TBL] [Abstract][Full Text] [Related]  

  • 72. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
    Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
    J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway.
    Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
    EBioMedicine; 2019 Aug; 46():66-78. PubMed ID: 31383552
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-32 promotes esophageal squamous cell carcinoma metastasis by targeting CXXC5.
    Liu YT; Zong D; Jiang XS; Yin L; Wang LJ; Wang TT; Zhu J; He X
    J Cell Biochem; 2019 Apr; 120(4):6250-6263. PubMed ID: 30362164
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.
    Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; He Z; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST
    PLoS One; 2015; 10(11):e0140642. PubMed ID: 26556718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. LncRNA LOC146880 promotes esophageal squamous cell carcinoma progression via miR-328-5p/FSCN1/MAPK axis.
    Tang J; Xu H; Liu Q; Zheng J; Pan C; Li Z; Wen W; Wang J; Zhu Q; Wang Z; Chen L
    Aging (Albany NY); 2021 May; 13(10):14198-14218. PubMed ID: 34016787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1.
    Mao Y; Li L; Liu J; Wang L; Zhou Y
    Oncotarget; 2016 Aug; 7(32):51223-51236. PubMed ID: 27323412
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PIK3C3 Acts as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and Was Regulated by MiR-340-5p.
    Wang X; Gu M; Ju Y; Zhou J
    Med Sci Monit; 2020 Mar; 26():e920642. PubMed ID: 32207410
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.
    Xiao Z; Feng X; Zhou Y; Li P; Luo J; Zhang W; Zhou J; Zhao J; Wang D; Wang Y; Tian Z; Zhao X
    Int J Nanomedicine; 2023; 18():95-114. PubMed ID: 36636641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.